Amalgamated Bank’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Hold |
2,570
| – | – | ﹤0.01% | 1646 |
|
|
2025
Q1 | $104K | Buy |
2,570
+410
| +19% | +$16.6K | ﹤0.01% | 1670 |
|
|
2024
Q4 | $60K | Hold |
2,160
| – | – | ﹤0.01% | 1795 |
|
|
2024
Q3 | $62K | Hold |
2,160
| – | – | ﹤0.01% | 1787 |
|
|
2024
Q2 | $51K | Buy |
2,160
+83
| +4% | +$1.96K | ﹤0.01% | 1847 |
|
|
2024
Q1 | $52K | Sell |
2,077
-5,247
| -72% | -$131K | ﹤0.01% | 1854 |
|
|
2023
Q4 | $171K | Sell |
7,324
-235
| -3% | -$5.49K | ﹤0.01% | 1841 |
|
|
2023
Q3 | $382K | Buy |
7,559
+1,166
| +18% | +$58.9K | ﹤0.01% | 1542 |
|
|
2023
Q2 | $298K | Buy |
6,393
+2,634
| +70% | +$123K | ﹤0.01% | 1672 |
|
|
2023
Q1 | $144K | Sell |
3,759
-844
| -18% | -$32.3K | ﹤0.01% | 1918 |
|
|
2022
Q4 | $252K | Buy |
4,603
+954
| +26% | +$52.2K | ﹤0.01% | 1766 |
|
|
2022
Q3 | $124K | Buy |
3,649
+152
| +4% | +$5.17K | ﹤0.01% | 2055 |
|
|
2022
Q2 | $33K | Sell |
3,497
-422
| -11% | -$3.98K | ﹤0.01% | 2659 |
|
|
2022
Q1 | $56K | Buy |
+3,919
| New | +$56K | ﹤0.01% | 2419 |
|